Alcobra Ltd (ADHD) - Financial and Strategic SWOT Analysis Review

Summary

Alcobra Ltd (Alcobra) is a pharmaceutical company that develops and commercializes proprietary pharmaceutical products and novel treatments for CNS. The company offers non-stimulant products that are used in treatment of central nervous system disorders and cognitive dysfunctions. It provides development and commercialization of its investigational new novel Phase III drug candidate, metadoxine extended release. Alcbras MDX acts as a monoamine-independent modulator of GABA transmission. The company conducts clinical studies and separate Phase IIb trials of MDX. It also provides phase II studies and a phase III study of MDX in adults with ADHD. Alcobra is headquartered in Tel Aviv, Israel.

Alcobra Ltd Key Recent Developments

Nov 09,2017: Alcobra Announces Third Quarter 2017 Financial Results and Provides Corporate Update
Aug 11,2017: Alcobra Announces Second Quarter 2017 Financial Results and Provides Corporate Update
Jun 23,2017: Alcobra Updates On Its Review Of Strategic Alternatives
May 30,2017: Alcobra Announces First Quarter 2017 Financial Results and Provides Corporate Update
May 15,2017: Alcobra Announces Leadership Update

This comprehensive SWOT profile of Alcobra Ltd provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Alcobra Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief Summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents

Section 1 - About the Company

Alcobra Ltd - Key Information
Alcobra Ltd - Overview
Alcobra Ltd - Key Employees
Alcobra Ltd - Key Employee Biographies
Alcobra Ltd - Key Operational Heads
Alcobra Ltd - Major Products and Services
Alcobra Ltd - History
Alcobra Ltd - Company Statement
Alcobra Ltd - Locations And Subsidiaries
Alcobra Ltd - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Alcobra Ltd - Business Description
Alcobra Ltd - Corporate Strategy
Alcobra Ltd - SWOT Analysis
SWOT Analysis - Overview
Alcobra Ltd - Strengths
Alcobra Ltd - Weaknesses
Alcobra Ltd - Opportunities
Alcobra Ltd - Threats
Alcobra Ltd - Key Competitors

Section 3 - Company Financial Performance Charts

Alcobra Ltd - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company

List Of Tables



Alcobra Ltd, Key Information
Alcobra Ltd, Key Ratios
Alcobra Ltd, Share Data
Alcobra Ltd, Major Products and Services
Alcobra Ltd, History
Alcobra Ltd, Key Employees
Alcobra Ltd, Key Employee Biographies
Alcobra Ltd, Key Operational Heads
Alcobra Ltd, Other Locations
Alcobra Ltd, Subsidiaries
Alcobra Ltd, Key Manufacturing facilities
Alcobra Ltd, Key Competitors
Alcobra Ltd, SWOT Analysis
Alcobra Ltd, Ratios based on current share price
Alcobra Ltd, Annual Ratios
Alcobra Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures



Alcobra Ltd, Performance Chart
Alcobra Ltd, Ratio Charts

Alcobra Ltd (ADHD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Alcobra Ltd (Alcobra) is a pharmaceutical company that develops and commercializes proprietary pharmaceutical products and novel treatments for CNS. The company offers non-stimulant products that are used in treatment of

USD 250 View Report

Alcobra Ltd (ADHD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Alcobra Ltd (Alcobra) is a pharmaceutical company that develops and commercializes proprietary pharmaceutical products and novel treatments for CNS. The company offers non-stimulant products that are used in treatment of

USD 250 View Report

Alcobra Ltd (ADHD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Alcobra Ltd (Alcobra) is a pharmaceutical company that develops and commercializes proprietary pharmaceutical products and novel treatments for CNS. The company offers non-stimulant products that are used in treatment of

USD 250 View Report

Alcobra Ltd (ADHD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Alcobra Ltd (Alcobra) is a pharmaceutical company that develops and commercializes proprietary pharmaceutical products and novel treatments for CNS. The company offers non-stimulant products that are used in treatment of

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available